[1] |
Severi G, Sinclair R, Hopper JL, et al. Androgenetic alopecia in men aged 40⁃69 years: prevalence and risk factors[J]. Br J Dermatol, 2003,149(6):1207⁃1213. doi: 10.1111/j.1365⁃2133. 2003.05565.x.
|
[2] |
Trüeb RM. Female pattern baldness in men[J]. J Am Acad Dermatol, 1993,29(5 Pt 1):782⁃783. doi: 10.1016/s0190⁃9622(08)81702⁃1.
|
[3] |
Lolli F, Pallotti F, Rossi A, et al. Androgenetic alopecia: a review[J]. Endocrine, 2017,57(1):9⁃17. doi: 10.1007/s12020⁃017⁃1280⁃y.
|
[4] |
Kerkemeyer KL, de Carvalho LT, Jerjen R, et al. Female pattern hair loss in men: a distinct clinical variant of androgenetic alopecia[J]. J Am Acad Dermatol, 2021,85(1):260⁃262. doi: 10.1016/j.jaad.2020.09.042.
|
[5] |
Paik JH, Yoon JB, Sim WY, et al. The prevalence and types of androgenetic alopecia in Korean men and women[J]. Br J Dermatol, 2001,145(1):95⁃99. doi: 10.1046/j.1365⁃2133.2001. 04289.x.
|
[6] |
Redler S, Messenger AG, Betz RC. Genetics and other factors in the aetiology of female pattern hair loss[J]. Exp Dermatol, 2017,26(6):510⁃517. doi: 10.1111/exd.13373.
|
[7] |
Nuwaihyd R, Redler S, Heilmann S, et al. Investigation of four novel male androgenetic alopecia susceptibility loci: no association with female pattern hair loss[J]. Arch Dermatol Res, 2014,306(4):413⁃418. doi: 10.1007/s00403⁃013⁃1436⁃4.
|
[8] |
Whiting DA. Diagnostic and predictive value of horizontal sections of scalp biopsy specimens in male pattern androgenetic alopecia[J]. J Am Acad Dermatol, 1993,28(5 Pt 1):755⁃763. doi: 10.1016/0190⁃9622(93)70106⁃4.
|
[9] |
Whiting DA. Chronic telogen effluvium: increased scalp hair shedding in middle⁃aged women[J]. J Am Acad Dermatol, 1996,35(6):899⁃906. doi: 10.1016/s0190⁃9622(96)90113⁃9.
|
[10] |
Sueki H, Stoudemayer T, Kligman AM, et al. Quantitative and ultrastructural analysis of inflammatory infiltrates in male pattern alopecia[J]. Acta Derm Venereol, 1999,79(5):347⁃350. doi: 10.1080/000155599750010238.
|
[11] |
Magro CM, Rossi A, Poe J, et al. The role of inflammation and immunity in the pathogenesis of androgenetic alopecia[J]. J Drugs Dermatol, 2011,10(12):1404⁃1411.
|
[12] |
Lattanand A, Johnson WC. Male pattern alopecia a histopathologic and histochemical study[J]. J Cutan Pathol, 1975,2(2):58⁃70. doi: 10.1111/j.1600⁃0560.1975.tb00209.x.
|
[13] |
Jaworsky C, Kligman AM, Murphy GF. Characterization of inflammatory infiltrates in male pattern alopecia: implications for pathogenesis[J]. Br J Dermatol, 1992,127(3):239⁃246. doi: 10.1111/j.1365⁃2133.1992.tb00121.x.
|
[14] |
Li H, Lin J, Yang K, et al. Inflammatory proteomics analysis in different types of male androgenetic alopecia[J]. Arch Dermatol Res, 2024,316(2):83. doi: 10.1007/s00403⁃024⁃02819⁃2.
|
[15] |
Arnold JN, Wormald MR, Sim RB, et al. The impact of glycosylation on the biological function and structure of human immunoglobulins[J]. Annu Rev Immunol, 2007,25:21⁃50. doi: 10.1146/annurev.immunol.25.022106.141702.
|
[16] |
Eichler J. Protein glycosylation[J]. Curr Biol, 2019,29(7):R229⁃R231. doi: 10.1016/j.cub.2019.01.003.
|
[17] |
García⁃Alija M, van Moer B, Sastre DE, et al. Modulating antibody effector functions by Fc glycoengineering[J]. Biotechnol Adv, 2023,67:108201. doi: 10.1016/j.biotechadv.2023.108201.
|
[18] |
Dekkers G, Treffers L, Plomp R, et al. Decoding the human immunoglobulin G⁃glycan repertoire reveals a spectrum of Fc⁃receptor⁃ and complement⁃mediated⁃effector activities[J]. Front Immunol, 2017,8:877. doi: 10.3389/fimmu.2017.00877.
|
[19] |
Norwood OT. Male pattern baldness: classification and incidence[J]. South Med J, 1975,68(11):1359⁃1365. doi: 10.1097/0000 7611⁃197511000⁃00009.
|
[20] |
Kerkemeyer KL, Poa JE, Trindade de Carvalho L, et al. Development and initial validation of a modified Sinclair scale for female pattern hair loss in men[J]. J Am Acad Dermatol, 2022,86(6):1406⁃1408. doi: 10.1016/j.jaad.2021.06.004.
|
[21] |
Gu Y, Duan B, Sha J, et al. Serum IgG N⁃glycans enable early detection and early relapse prediction of colorectal cancer[J]. Int J Cancer, 2023,152(3):536⁃547. doi: 10.1002/ijc.34298.
|
[22] |
Plante J, Valdebran M, Forcucci J, et al. Perifollicular inflammation and follicular spongiosis in androgenetic alopecia[J]. J Am Acad Dermatol, 2022,86(2):437⁃438. doi: 10.1016/j.jaad.2021.09.040.
|
[23] |
Wang TL, Zhou C, Shen YW, et al. Prevalence of androgenetic alopecia in China: a community⁃based study in six cities[J]. Br J Dermatol, 2010,162(4):843⁃847. doi: 10.1111/j.1365⁃2133. 2010.09640.x.
|
[24] |
Ho CY, Chen JY, Hsu WL, et al. Female pattern hair loss: an overview with focus on the genetics[J]. Genes (Basel), 2023,14(7):1326. doi: 10.3390/genes14071326.
|
[25] |
Baum LG, Cobb BA. The direct and indirect effects of glycans on immune function[J]. Glycobiology, 2017,27(7):619⁃624. doi: 10.1093/glycob/cwx036.
|
[26] |
Cobb BA. The history of IgG glycosylation and where we are now[J]. Glycobiology, 2020,30(4):202⁃213. doi: 10.1093/glycob/cwz065.
|
[27] |
Jennewein MF, Alter G. The immunoregulatory roles of antibody glycosylation[J]. Trends Immunol, 2017,38(5):358⁃372. doi: 10.1016/j.it.2017.02.004.
|
[28] |
Sonneveld ME, van der Schoot CE, Vidarsson G. The elements steering pathogenesis in IgG⁃mediated alloimmune diseases[J]. J Clin Immunol, 2016,36(Suppl 1):76⁃81. doi: 10.1007/s10875⁃016⁃0253⁃x.
|
[29] |
Anthony RM, Wermeling F, Ravetch JV. Novel roles for the IgG Fc glycan[J]. Ann N Y Acad Sci, 2012,1253:170⁃180. doi: 10.1111/j.1749⁃6632.2011.06305.x.
|
[30] |
Jefferis R. Antibody therapeutics: isotype and glycoform selection[J]. Expert Opin Biol Ther, 2007,7(9):1401⁃1413. doi: 10.1517/14712598.7.9.1401.
|